Allergenspezifische Immuntherapie bei Schimmelpilzallergien
Authors:
- 10 June 2024
- journal article
- research article
- Published by Springer Nature in Allergo Journal
- Vol. 33 (4) , 16-23
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Double-blind, randomized, placebo-controlled trial of allergen-specific immunotherapy with the major allergen Alt a 1Journal of Allergy and Clinical Immunology, 2019
- How Do Storms Affect Asthma?Current Allergy and Asthma Reports, 2018
- Efficacy and safety of immunotherapy for allergies to Alternaria alternata in childrenJournal of Allergy and Clinical Immunology, 2011
- Epidemic asthma and the role of the fungal mold Alternaria alternataJournal of Allergy and Clinical Immunology, 2007
- It's blowing in the wind: New insights into thunderstorm-related asthmaJournal of Allergy and Clinical Immunology, 2007
- The Risk of Asthma in Children Sensitized to AlternariaJournal of Allergy and Clinical Immunology, 2007
- Alternaria-induced asthmaJournal of Allergy and Clinical Immunology, 2004
- Sensitivity to fungal allergens is a risk factor for life‐threatening asthmaAllergy, 2000
- Association of sensitization to Alternaria allergens with asthma among school-age childrenJournal of Allergy and Clinical Immunology, 1998
- Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extractJournal of Allergy and Clinical Immunology, 1990